The MDCG has released new guidance on borderline cases between medical devices and medicinal products under the Medical Devices Regulation 2017/745. This guidance addresses several concepts such as the definition of a medicinal product, medical diagnosis, pharmacological, immunological and metabolic means, among others. Under the concept of principal intended action, it is . . .
Oh! It looks like you do not have access to this page.
Find the membership plan that suits you, and within a few minutes you are good to go.
Are you a member already? Log in here.